A comprehensive view of biopharmaceuticals/biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Dutch biotech firm UniQure’s Hemgenix injectable to treat hemophilia B, making it the first gene therapy treatment for the disorder; Australian drugmaker CSL has license for the treatment and places list price at US$3.5M
Published: November 23, 2022 by BioPharma Dive
FujiFilm invests US$188.0M in 250,000 square-foot cell culture media manufacturing plant in North Carolina’s Research Triangle Park; facility to expand FujiFilm's capacity to 800,000 kilograms of dry powder and 3,300,000 liters of liquid annually
Published: November 22, 2022 by FiercePharma
Oxford Biomedica names Frank Mathias as CEO effective March 2023 to replace former CEO John Dawson, who has retired from the firm; Mathias formerly served as CEO at Rentschler Biopharma
Published: November 22, 2022 by CE Noticias Financieras
AstraZeneca’s Alexion completes US$68.0M acquisition of LogicBio Therapeutics; LogicBio has developed tech platforms to deliver and insert genes to address genetic diseases and a platform to improve viral vector manufacturing processes
Published: November 22, 2022 by Indian Pharma Industry: Policies
Organicell Regenerative Medicine announces clinical trial of Zofin naturally derived, acellular, exosome-based therapeutic to treat Long COVID; Bloomberg reports Long COVID affects at least 140 million people worldwide
Published: November 21, 2022 by Accesswire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count